Innovative Diagnostic Solutions Cue Health’s focus on real-time, lab-quality diagnostics, including at-home COVID-19 tests and upcoming respiratory and infectious disease panels, presents opportunities for healthcare providers and institutions seeking reliable point-of-care testing solutions to enhance patient care and safety.

Strategic Partnerships Recent collaborations with Tarsadia Investments and federal agencies like BARDA demonstrate Cue's capacity to develop advanced molecular tests, signaling potential for partnership or sales of specialized diagnostic platforms and consumables to government and private sector clients engaged in public health initiatives.

Market Expansion Needs Given Cue’s recent financial struggles and workforce reductions, there may be a demand for cost-effective and scalable diagnostic technologies that help optimize operational efficiency and reduce costs, creating opportunities to offer complementary products or services to improve margins.

Growth in Federal Funding With significant federal contracts awarded for developing multiplex respiratory tests, there is a clear opportunity to position additional diagnostic solutions for government health agencies, clinics, and hospitals seeking to meet national preparedness and response requirements.

Telehealth Integration Cue’s empowering healthcare technology aligns with the growing trend of telehealth services, offering potential sales avenues for remote diagnostic devices and integrated health data platforms that enable seamless virtual care coordination and patient monitoring.